Assessing the Impact of Direct-to-Consumer Advertising (DTCA) on Consumer Behavior

How to cite

Eisenberg, Matthew; Sood, Neeraj. 2020. "Assessing the Impact of Direct-to-Consumer Advertising (DTCA) on Consumer Behavior." AEA RCT Registry. AEARCTR-0006690. https://doi.org/10.1257/rct.6690-1.1

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Matthew Eisenberg* , Neeraj Sood

* Primary investigator

Registry ID
AEARCTR-0006690
DOI
https://doi.org/10.1257/rct.6690-1.1
First registered
Last updated
Status
On going
Trial dates
2021-01-15 – 2021-12-31
Countries
Private
JEL codes
D83 Search, Learning, Information and Knowledge, I12 Health Behavior, K32 Energy, Environmental, Health, and Safety Law
Registry record
http://www.socialscienceregistry.org/trials/6690

Abstract

Consumers in the United States are being exposed to unprecedented high levels of pharmaceutical direct-to-consumer-advertising (DTCA), with $5.63 billion spent in 2015. Prior work has identified associations between DTCA and rising prescription drug utilization using observational data, but the causal impact of DTCA is unclear. In order to concretely identify and estimate the effects of DTCA, we design a randomized experiment to examine the effects of DTCA on the use of drugs, health related behaviors, and information seeking behaviors, as well as the effects of price disclosure on behavioral intentions and consumer behavior.

Experimental design

We will be fielding an experiment with randomized assignment of participants to three possible study arms: DTCA (Treatment 1), DTCA with prices (Treatment 2), and non-drug advertising (Control Group).

Design details

Randomization method
Randomization done in an office by a computer
Randomization unit
Individual
Clusters
N/A
Observations
We will recruit participants currently using a prescription drug for cardiovascular disease or at high risk for cardiovascular disease. Specifically, we will include English speaking United States residents aged 40-64 who have been diagnosed with cardiovascular disease or are currently are a cigarette smoker or are obese. We will be aiming for 675 participants in each experiment arm, for a total of 2,025 participants across all arms. Sample sizes have been confirmed with Ipsos, the online survey research firm, and have been deemed feasible given their current survey panels and reach.
Arms
We will be aiming for 675 participants in each experiment arm, for a total of 2,025 participants across all arms.
Primary outcomes
Outcome measures include the likelihood of participants taking the drug as directed, switching drugs, asking their physician about the drug, asking their insurer about the drug, researching the drug online, having intentions to eat healthier food and be physically active, and actually eating healthier food and being physically active.

Cited by

No citation data available for this registration yet.

Keywords